Insider Transactions in Q4 2023 at Mi Nk Therapeutics, Inc. (INKT)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 01
2023
|
Barbara Ryan |
BUY
Grant, award, or other acquisition
|
Direct |
17,068
+20.08%
|
$17,068
$1.04 P/Share
|
|
Dec 01
2023
|
Peter Behner |
BUY
Grant, award, or other acquisition
|
Direct |
14,784
+20.08%
|
$14,784
$1.04 P/Share
|
|
Dec 01
2023
|
Ulf Wiinberg |
BUY
Grant, award, or other acquisition
|
Direct |
14,424
+16.21%
|
$14,424
$1.04 P/Share
|
|
Dec 01
2023
|
Brian Corvese |
BUY
Grant, award, or other acquisition
|
Direct |
17,188
+4.72%
|
$17,188
$1.04 P/Share
|
|
Oct 16
2023
|
Agenus Inc |
BUY
Open market or private purchase
|
Direct |
429
+0.0%
|
$429
$1.1 P/Share
|
|
Oct 13
2023
|
Agenus Inc |
BUY
Open market or private purchase
|
Direct |
19,373
+0.09%
|
$19,373
$1.1 P/Share
|
|
Oct 12
2023
|
Agenus Inc |
BUY
Open market or private purchase
|
Direct |
3,173
+0.01%
|
$3,173
$1.1 P/Share
|
|
Oct 11
2023
|
Jennifer Buell Chief Executive Officer |
SELL
Other acquisition or disposition
|
Direct |
695,750
-74.98%
|
-
|
|
Oct 04
2023
|
Agenus Inc |
BUY
Open market or private purchase
|
Direct |
15,001
+0.07%
|
$15,001
$1.09 P/Share
|
|
Oct 03
2023
|
Jennifer Buell Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
65,000
-6.55%
|
$0
$0.94 P/Share
|
|
Oct 02
2023
|
Jennifer Buell Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
58,550
-5.57%
|
$58,550
$1.04 P/Share
|